Scientific Advisory Board

Proneuron has attracted world-renowned individuals from science and industry to its advisory board. These individuals bring significant technical and commercial experience to the Company in addition to serving as educators in order to garner greater market acceptance to the Company's ultimate goals and products.

---

Professor Michal Schwartz
Chairperson of the company's Scientific Advisory Board

Prof. Michael Belkin
Professor of Ophthalmology, Goldschleger Eye Research Institute, Tel-Aviv University, Israel

Prof. Edward Benzel
Director, Spinal Disorders, Dept. Neurosurgery, The Cleveland Clinic Foundation, Cleveland, Ohio, U.S.

Prof. Jacques Brotchi, MD, PhD
Professor and Chair of Neurosurgery, Universite Libre de Bruxelles, Brussels, Belgium

Prof. Irun Cohen
Dept. Immunology, Weizmann Institute of Science, Israel

Dr. Reuven Gepstein
Meir Hospital, Kfar Saba, Israel

Prof. Siamon Gordon
Sir William Dunn School of Pathology, University of Oxford, Oxford, England

Dr. Moshe Hadani
Head, Neurosurgery Department, Sheba Medical Center, Tel-Hashomer, Israel

Prof. Paul F. Kaufman
Professor and Director of Glaucoma Services, University of Wisconsin Madison Medical School, Madison, Wisconsin, U.S.

Dr. Nachshon Knoller
Head of Spinal Disorders Unit, Sheba Medical Center, Tel-Hashomer, Israel

Prof. Harry Rappaport
Head, Neurosurgery Department, Rabin Medical Center, Petach Tikva, Israel

Prof. Charles H. Tator, MD, PhD, FRCSC
Professor and Chair of Neurosurgery at the University of Toronto, Toronto, Canada

Dr. Ben-Zion Weiner
Corporate Vice-President of Research & Development, Teva Pharmaceutical Industries

Prof. Howard L. Weiner, M.D.
Director, Multiple Sclerosis Program Center for Neurological Diseases Harvard Medical School, Cambridge, MA, U.S.

Dr. Daniel Lammertse, M.D
Medical Director of Craig Hospital, Denver, CO, U.S.